日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Australian Clinical Trial Authors' Declarations of Industry Ties

澳大利亚临床试验作者关于行业关系的声明

期刊:Journal of General Internal Medicine
影响因子:4.2
doi:10.1007/s11606-022-07466-9
Flood, Lorelie; Mintzes, Barbara; Chiu, Kellia; Dai, Zhaoli; Karanges, Emily A; Holman, Bennett
发表日期：2022
文献求助 收藏

A comparison of educational events for physicians and nurses in Australia sponsored by opioid manufacturers

对澳大利亚由阿片类药物生产商赞助的面向医生和护士的教育活动进行比较

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0248238
Grundy, Quinn; Mazzarello, Sasha; Brennenstuhl, Sarah; Karanges, Emily A
发表日期：2021
文献求助 收藏

Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study

澳大利亚制药行业付款与辅助生殖：一项回顾性观察研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2021-049710
Karanges, Emily Aspasia; Nangla, Conrad; Parker, Lisa; Fabbri, Alice; Farquhar, Cynthia; Bero, Lisa
发表日期：2021
文献求助 收藏

The changing face of Australian data reforms: impact on pharmacoepidemiology research

澳大利亚数据改革的变迁：对药物流行病学研究的影响

期刊:International Journal of Population Data Science
影响因子:2.2
doi:10.23889/ijpds.v6i1.1418
de Oliveira Costa, Juliana; Bruno, Claudia; Schaffer, Andrea L; Raichand, Smriti; Karanges, Emily A; Pearson, Sallie-Anne
发表日期：2021
文献求助 收藏

Understanding the Nature and Extent of Pharmaceutical Industry Payments to Nonphysician Clinicians

了解制药行业向非医生临床人员支付款项的性质和范围

期刊:Jama Internal Medicine
影响因子:23.3
doi:10.1001/jamainternmed.2019.1371
Karanges, Emily A; Grundy, Quinn; Bero, Lisa
发表日期：2019
文献求助 收藏

Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study

澳大利亚一项基于人群的研究表明，在对含纳洛酮的羟考酮制剂进行补贴后，控释羟考酮的使用量有所增加。

期刊:Pharmacoepidemiology and Drug Safety
影响因子:2.4
doi:10.1002/pds.4683
Schaffer, Andrea L; Karanges, Emily A; Buckley, Nicholas A; Wilson, Andrew; Degenhardt, Louisa; Larance, Briony; Pearson, Sallie-Anne
发表日期：2019
文献求助 收藏

Trends in self-poisoning and psychotropic drug use in people aged 5-19 years: a population-based retrospective cohort study in Australia

澳大利亚5-19岁人群自杀性中毒和精神药物使用趋势：一项基于人群的回顾性队列研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2018-026001
Cairns, Rose; Karanges, Emily A; Wong, Anselm; Brown, Jared A; Robinson, Jeff; Pearson, Sallie-Anne; Dawson, Andrew H; Buckley, Nicholas A
发表日期：2019
文献求助 收藏

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study

澳大利亚制药公司披露的支出类型和金额的变化：一项观察性研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2018-024928
Parker, Lisa; Karanges, Emily A; Bero, Lisa
发表日期：2019
文献求助 收藏

Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey

澳大利亚全科医生对医用大麻的认知和态度：一项横断面调查

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2018-022101
Karanges, Emily A; Suraev, Anastasia; Elias, Natalie; Manocha, Ramesh; McGregor, Iain S
神经科学
发表日期：2018
文献求助 收藏

Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study

2006年至2015年澳大利亚精神药物多重用药情况：一项描述性队列研究

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.13369
Brett, Jonathan; Daniels, Benjamin; Karanges, Emily A; Buckley, Nicholas A; Schneider, Carl; Nassir, Atheer; McLachlan, Andrew J; Pearson, Sallie-Anne
发表日期：2017
文献求助 收藏